S

Scenic Biotech

55 employees

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immuno-oncology
Disease
Life Science
Biology
Oncology
Science
Pharmaceuticals
Technology
Rare disease
Medicine
Biometrics
Collaborative Consumption

Date founded

2017

Funding rounds raised

Total raised

$31M

from 10 investors over 10 rounds

S

Scenic Biotech raised $31M on March 10, 2022

Investors: Oxford Sciences Innovation, Eir Ventures, BGV (BioGeneration Ventures), BioMedPartners and Inkef

S

Scenic Biotech raised $3.5M on June 23, 2020

Investors: Netherlands Enterprise Agency (RVO)

S

Scenic Biotech raised $7.3M on June 5, 2017

Investors: Oxford Sciences Innovation, BGV (BioGeneration Ventures), Isis Enterprise of Isis Innovation Ltd. and Inkef

FAQ